Medline, Inc. Class A (MDLN)
NASDAQ:MDLN
Want to see MDLN full AI Analyst Report?
MDLN Stock Chart & Stats
$47.64
--
Market closed
$47.64
--
Day’s Range― - ―
52-Week Range$34.89 - $50.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.36M
Market Cap
$47.50B
Enterprise Value$41.63B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$12.57B
Price to Earnings (P/E)70.6
Beta1.19
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.21
Shares Outstanding845,606,200
10 Day Avg. Volume12,571,948
30 Day Avg. Volume8,356,107
Financial Highlights & Ratios
PEG Ratio-4.97
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio19.56
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue1.43
Enterprise Value/Gross Profit5.94
Enterprise Value/Ebitda14.14
Forecast
1Y Price Target
$52.40Price Target Upside9.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
EPS Forecast (FY)1.51
Revenue Forecast (FY)$31.09B
Bulls Say, Bears Say
Bulls Say
Revenue ScalingSustained revenue scaling indicates expanding penetration across hospitals, health systems and other care settings and supports long-term contract leverage. Over a 2–6 month horizon this trend implies higher recurring order volumes, better bargaining power with suppliers, and greater ability to fund operations and strategic investments.
Improving Gross MarginA multi-year rise in gross margin signals durable improvements in pricing, product mix, or cost control rather than one-off gains. This enhances operating leverage, bolsters free cash flow potential and provides a structural buffer against input inflation, supporting sustainable profitability and reinvestment capacity over coming quarters.
Solid Cash GenerationConsistent operating cash flow and improving FCF conversion in 2025 provide durable financial flexibility to fund working capital, capex and debt service. Reliable cash generation supports strategic initiatives and reduces reliance on external financing, strengthening medium-term resilience despite episodic earnings volatility.
Bears Say
High LeverageDebt near parity with equity and a rising leverage ratio materially reduces financial flexibility. In a downturn or under margin pressure this elevated leverage increases interest burden and constrains capital allocation, limiting the company's ability to invest in growth, absorb shocks, or opportunistically deleverage.
Margin VolatilityDeclines and swings in net and operating margins imply that revenue growth doesn't consistently translate to profit. Persistent margin variability undermines forecasting, reduces incremental free cash flow per dollar of revenue, and raises execution risk for sustaining investment in distribution and manufacturing capabilities.
Uneven Earnings-to-Cash ConversionA recurring gap where OCF covers substantially less than reported net income signals working-capital swings or non-cash timing effects. This makes earnings less reliable as a cash proxy, complicates debt servicing plans and capital allocation decisions, and elevates the risk that reported profits won’t support future cash needs.
Medline News
MDLN FAQ
What was Medline, Inc. Class A’s price range in the past 12 months?
Medline, Inc. Class A lowest stock price was $34.89 and its highest was $50.88 in the past 12 months.
What is Medline, Inc. Class A’s market cap?
Medline, Inc. Class A’s market cap is $47.50B.
When is Medline, Inc. Class A’s upcoming earnings report date?
Medline, Inc. Class A’s upcoming earnings report date is Mar 03, 2027 which is in 279 days.
How were Medline, Inc. Class A’s earnings last quarter?
Medline, Inc. Class A released its earnings results on May 06, 2026. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.295 by $0.035.
Is Medline, Inc. Class A overvalued?
According to Wall Street analysts Medline, Inc. Class A’s price is currently Undervalued.
Does Medline, Inc. Class A pay dividends?
Medline, Inc. Class A does not currently pay dividends.
What is Medline, Inc. Class A’s EPS estimate?
Medline, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medline, Inc. Class A have?
Medline, Inc. Class A has 845,606,200 shares outstanding.
What happened to Medline, Inc. Class A’s price movement after its last earnings report?
Medline, Inc. Class A reported an EPS of $0.33 in its last earnings report, beating expectations of $0.295. Following the earnings report the stock price went down -7.304%.
Which hedge fund is a major shareholder of Medline, Inc. Class A?
Currently, no hedge funds are holding shares in MDLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medline Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.40 (9.99% Upside)
$52.40 (9.99% Upside)
Blogger Sentiment
Bullish
MDLN Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 7.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 9.6%
Last 30 Days ▼ 9.6%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Company Description
Medline, Inc. Class A
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
MDLN Company Deck
MDLN Earnings Call
Q1 2026
0:00 / 0:00
MDLN Stock 12 Month Forecast
Average Price Target
$52.40
▲(9.99% Upside)
Baxter International
―
Becton Dickinson
―
ICU Medical
―
Merit Medical Systems
―
Teleflex
―